4//SEC Filing
SATO VICKI L 4
Accession 0001628280-26-000320
CIK 0001706431other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 1:57 PM ET
Size
5.2 KB
Accession
0001628280-26-000320
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2026-01-02$5.93/sh−22,000$130,383→ 1,166,391 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.84 to $6.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001197020
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 1:57 PM ET
- Size
- 5.2 KB